Page last updated: 2024-10-22

amantadine and Granulomatous Disease, Chronic

amantadine has been researched along with Granulomatous Disease, Chronic in 2 studies

amant: an antiviral compound consisting of an adamantane derivative chemically linked to a water-solube polyanioic matrix; structure in first source

Granulomatous Disease, Chronic: A defect of leukocyte function in which phagocytic cells ingest but fail to digest bacteria, resulting in recurring bacterial infections with granuloma formation. When chronic granulomatous disease is caused by mutations in the CYBB gene, the condition is inherited in an X-linked recessive pattern. When chronic granulomatous disease is caused by CYBA, NCF1, NCF2, or NCF4 gene mutations, the condition is inherited in an autosomal recessive pattern.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Granzotto, M1
Leone, V1
Lepore, L1
Zerial, M1
Tommasini, A1
Ciambra, R1
Gombac, F1
Ventura, A1
Warner, JO1

Other Studies

2 other studies available for amantadine and Granulomatous Disease, Chronic

ArticleYear
Amantadine in chronic granulomatous disease.
    Pediatric hematology and oncology, 2005, Volume: 22, Issue:2

    Topics: Adult; Amantadine; Candida albicans; Case-Control Studies; Cells, Cultured; Drug Evaluation; Granulo

2005
Amantadine in chronic granulomatous disease.
    Lancet (London, England), 1985, Aug-24, Volume: 2, Issue:8452

    Topics: Amantadine; Child, Preschool; Granulomatous Disease, Chronic; Humans; Male

1985